Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEANORA: Ribociclib PK/PGx in Race-based Cohorts
NCT04657679Phase 4Terminated
- Sponsor
- Georgetown University
- Start
- May 2021
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ribociclib in breast cancer, sponsored by Georgetown University. Started May 2021; status: terminated.
02
Drugs
ribociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04657679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04657679.